Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 695

1.

Peripheral arterial disease and methylenetetrahydrofolate reductase (MTHFR) C677T mutations: A case-control study and meta-analysis.

Khandanpour N, Willis G, Meyer FJ, Armon MP, Loke YK, Wright AJ, Finglas PM, Jennings BA.

J Vasc Surg. 2009 Mar;49(3):711-8. doi: 10.1016/j.jvs.2008.10.004. Epub 2009 Jan 21. Review.

2.

Factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations are not associated with chronic limb ischemia: the Linz Peripheral Arterial Disease (LIPAD) study.

Mueller T, Marschon R, Dieplinger B, Haidinger D, Gegenhuber A, Poelz W, Webersinke G, Haltmayer M.

J Vasc Surg. 2005 May;41(5):808-15.

3.

The C677T mutation in methylenetetrahydrofolate reductase gene, plasma homocysteine concentration and the risk of coronary artery disease.

Kadziela J, Janas J, Dzielińska Z, Szperl M, Gaździk D, Chotkowska E, Piotrowski W, Ruzyłło W.

Kardiol Pol. 2003 Jul;59(7):17-26; discussion 26.

PMID:
14560345
4.

Higher incidence of C677T polymorphism of the MTHFR gene in North Indian patients with vascular disease.

Bhargava S, Ali A, Parakh R, Saxena R, Srivastava LM.

Vascular. 2012 Apr;20(2):88-95. doi: 10.1258/vasc.2011.oa0320. Epub 2012 Feb 28.

PMID:
22375042
5.
6.

Hyperhomocysteinaemia, low folate concentrations and methylene tetrahydrofolate reductase C677T mutation in acute mesenteric venous thrombosis.

He JA, Hu XH, Fan YY, Yang J, Zhang ZS, Liu CW, Yang DH, Zhang J, Xin SJ, Zhang Q, Duan ZQ.

Eur J Vasc Endovasc Surg. 2010 Apr;39(4):508-13. doi: 10.1016/j.ejvs.2009.09.014. Epub 2009 Oct 20.

7.

Correlation between C677T MTHFR gene polymorphism, plasma homocysteine levels and the incidence of CAD.

Nakai K, Itoh C, Nakai K, Habano W, Gurwitz D.

Am J Cardiovasc Drugs. 2001;1(5):353-61. Review.

PMID:
14728017
8.

Prevalence of hyperhomocysteinemia and the MTHFR C677T polymorphism in patients with arterial and venous thrombosis from North Western Russia.

Shmeleva VM, Kapustin SI, Papayan LP, Sobczyńska-Malefora A, Harrington DJ, Savidge GF.

Thromb Res. 2003;111(6):351-6.

PMID:
14698652
9.

5,10-Methylenetetrahydrofolate reductase C677T gene polymorphism in Behcet's patients with or without ocular involvement.

Ozkul Y, Evereklioglu C, Borlu M, Taheri S, Calis M, Dündar M, Ilhan O.

Br J Ophthalmol. 2005 Dec;89(12):1634-7.

10.
11.

Association study between methylenetetrahydrofolate reductase polymorphisms and unexplained recurrent pregnancy loss: a meta-analysis.

Cao Y, Xu J, Zhang Z, Huang X, Zhang A, Wang J, Zheng Q, Fu L, Du J.

Gene. 2013 Feb 10;514(2):105-11. doi: 10.1016/j.gene.2012.10.091. Epub 2012 Nov 29.

PMID:
23201418
12.

Methylenetetrahydrofolate reductase (C677T and A1298C) polymorphisms, hyperhomocysteinemia, and ischemic stroke in Tunisian patients.

Fekih-Mrissa N, Mrad M, Klai S, Mansour M, Nsiri B, Gritli N, Mrissa R.

J Stroke Cerebrovasc Dis. 2013 May;22(4):465-9. doi: 10.1016/j.jstrokecerebrovasdis.2013.03.011.

PMID:
23642756
13.

Methylenetetrahydrofolate reductase gene, homocysteine and coronary artery disease: the A1298C polymorphism does matter. Inferences from a case study (Madeira, Portugal).

Freitas AI, Mendonça I, Guerra G, Brión M, Reis RP, Carracedo A, Brehm A.

Thromb Res. 2008;122(5):648-56. doi: 10.1016/j.thromres.2008.02.005. Epub 2008 Apr 1.

PMID:
18384842
15.

Polymorphism of the methylenetetrahydrofolate reductase gene association with homocysteine and ischemic stroke in type 2 diabetes.

Sun JZ, Xu Y, Lu H, Zhu Y.

Neurol India. 2009 Sep-Oct;57(5):589-93. doi: 10.4103/0028-3886.57808.

16.

Methylenetetrahydrofolate reductase (MTHFR) gene C677T, A1298C and G1793A polymorphisms: association with risk for clear cell renal cell carcinoma and tumour behaviour in men.

Safarinejad MR, Shafiei N, Safarinejad S.

Clin Oncol (R Coll Radiol). 2012 May;24(4):269-81. doi: 10.1016/j.clon.2011.03.005. Epub 2011 Apr 13.

PMID:
21489764
17.

Methylenetetrahydrofolate reductase polymorphisms and breast cancer risk: a meta-analysis from 41 studies with 16,480 cases and 22,388 controls.

Qi X, Ma X, Yang X, Fan L, Zhang Y, Zhang F, Chen L, Zhou Y, Jiang J.

Breast Cancer Res Treat. 2010 Sep;123(2):499-506. doi: 10.1007/s10549-010-0773-7. Epub 2010 Feb 5.

PMID:
20135343
18.

Methylenetetrahydrofolate reductase C677T polymorphism in Iraqi patients with ischemic stroke.

Al-Allawi NA, Avo AS, Jubrael JM.

Neurol India. 2009 Sep-Oct;57(5):631-5. doi: 10.4103/0028-3886.57821.

19.

Methylenetetrahydrofolate reductase C677T and A1298C polymorphism and changes in homocysteine concentrations in women with idiopathic recurrent pregnancy losses.

Mtiraoui N, Zammiti W, Ghazouani L, Braham NJ, Saidi S, Finan RR, Almawi WY, Mahjoub T.

Reproduction. 2006 Feb;131(2):395-401.

20.

MTHFR C677T polymorphism associated with breast cancer susceptibility: a meta-analysis involving 15,260 cases and 20,411 controls.

Zhang J, Qiu LX, Wang ZH, Wu XH, Liu XJ, Wang BY, Hu XC.

Breast Cancer Res Treat. 2010 Sep;123(2):549-55. doi: 10.1007/s10549-010-0783-5. Epub 2010 Feb 9.

PMID:
20143151

Supplemental Content

Support Center